The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Abstract
Both alcoholic liver disease (ALD) and nonalcoholic fatty liver disease are characterized by massive lipid accumulation in the liver accompanied by inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma in a substantial subgroup of patients. At several stages in these diseases, mediators of the immune system, such as cytokines or inflammasomes, are crucially involved. In ALD, chronic ethanol exposure sensitizes Kupffer cells to activation by lipopolysaccharides through Toll‐like receptors, e.g., Toll‐like receptor 4. This sensitization enhances the production of various proinflammatory cytokines such as interleukin‐1 (IL‐1) and tumor necrosis factor‐alpha, thereby contributing to hepatocyte dysfunction, necrosis, and apoptosis and the generation of extracellular matrix proteins leading to fibrosis/cirrhosis. Indeed, neutralization of IL‐1 by IL‐1 receptor antagonist has recently been shown to potently prevent liver injury in murine models of ALD. As IL‐1 is clearly linked to key clinical symptoms of acute alcoholic hepatitis such as fever, neutrophilia, and wasting, interfering with the IL‐1 pathway might be an attractive treatment strategy in the future. An important role for IL‐1‐type cytokines and certain inflammasomes has also been demonstrated in murine models of nonalcoholic fatty liver disease. IL‐1‐type cytokines can regulate hepatic steatosis; the NLR family pyrin domain containing 3 inflammasome is critically involved in metabolic dysregulation. Conclusion: IL‐1 cytokine family members and various inflammasomes mediate different aspects of both ALD and nonalcoholic fatty liver disease. (H epatology 2016;64:955‐965)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Self-citationInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945 · cited 3×
“These mediators are mainly proinflammatory but can also be anti-inflammatory and are important in almost all inflammatory conditions, exerting their specific effects through IL-1Rs 1-10.((6)) They are also involved in the differentiation and function of many innate and lymphoid cells, direct many complex inflammatory…”
BackgroundInfluentialTreating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,682
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Yki-Järvinen, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70032-4 · Cited by 1,259
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 948
Self-citationChen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Lucey, M. R., Mathurin, P., & Morgan, T. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0805786 · Cited by 863
IL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
Self-citationToll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Serum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739
Self-citationIL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60777 · Cited by 735
Antibiotics prevent liver injury in rats following long-term exposure to ethanol
Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90027-6 · Cited by 692
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Sterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
Self-citationWeight loss regulates inflammation‐related genes in white adipose tissue of obese subjects
ClÉment, K., Viguerie, N., Poitou, C., Carette, C., Pelloux, V., Curat, C. A., Sicard, A., Rome, S., Benis, A., Zucker, J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2204com · Cited by 640
Inflammasome activation and function in liver disease
Szabo, G., & Petrasek, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.94 · Cited by 597
Self-citationIL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 522
Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH2-terminal Kinases
Lo, Y. Y. C., Wong, J. M. S., & Cruz, T. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15703 · Cited by 497
Inflammasomes in liver diseases
Szabo, G., & Csak, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.035 · Cited by 495
Self-citationSakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Wree, A., McGeough, M. D., Peña, C. A., Schlattjan, M., Li, H., Inzaugarat, M. E., Messer, K., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1170-1 · Cited by 486
Increased Plasma Tumor Necrosis Factor in Severe Alcoholic Hepatitis
Bird, G. L. A., Sheron, N., Goka, A. K. J., Alexander, G. J., & Williams, R. S. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-917 · Cited by 458
Stienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452
Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability
Al-Sadi, R., Ye, D., Dokladny, K., & Ma, T. Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5653 · Cited by 417
Hritz, I., Mandrekar, P., Velayudham, A., Catalano, D., Dolganiuc, A., Kodys, K., Kurt‐Jones, E., & Szabo, G. (2008) · Hepatology · doi:10.1002/hep.22470 · Cited by 415
Self-citationKeshavarzian, A., Farhadi, A., Forsyth, C. B., Rangan, J., Jakate, S., Shaikh, M., Banan, A., & Fields, J. Z. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.028 · Cited by 359
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Boetticher, N. C., Peine, C. J., Kwo, P., Abrams, G. A., Patel, T., Aqel, B., Boardman, L., Gores, G. J., Harmsen, W. S., McClain, C. J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.057 · Cited by 340
Mookerjee, R. P., Stadlbauer, V., Lidder, S., Wright, G. A. K., Hodges, S. J., Davies, N. A., & Jalan, R. (2007) · Hepatology · doi:10.1002/hep.21737 · Cited by 332
Gäbele, E., Dostert, K., Hofmann, C., Wiest, R., Schölmerich, J., Hellerbrand, C., & Obermeier, F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.035 · Cited by 324
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
Lagathu, C., Yvan-Charvet, L., Bastard, J.-P., Maachi, M., Quignard-Boulangé, A., Capeau, J., & Caron, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0335-z · Cited by 321
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice
Lu, Y., Zhuge, J., Wang, X., Bai, J., & Cederbaum, A. I. (2008) · Hepatology · doi:10.1002/hep.22222 · Cited by 311
Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.-D., Iwakura, Y., Hersberger, M., & Kopf, M. (2013) · Nature Immunology · doi:10.1038/ni.2704 · Cited by 307
Adipose Tissue Is a Major Source of Interleukin-1 Receptor Antagonist
Juge-Aubry, C. E., Somm, E., Giusti, V., Pernin, A., Chicheportiche, R., Verdumo, C., Rohner-Jeanrenaud, F., Burger, D., Dayer, J.-M., & Meier, C. A. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1104 · Cited by 305
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Chachay, V. S., Macdonald, G. A., Martin, J. H., Whitehead, J. P., O'Moore–Sullivan, T. M., Lee, P., Franklin, M., Klein, K., Taylor, P. J., Ferguson, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.024 · Cited by 289
Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8351 · Cited by 287
Kamari, Y., Shaish, A., Vax, E., Shemesh, S., Kandel-Kfir, M., Arbel, Y., Olteanu, S., Barshack, I., Dotan, S., Voronov, E., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.048 · Cited by 287
Miura, K., Yang, L., van Rooijen, N., Brenner, D. A., Ohnishi, H., & Seki, E. (2013) · Hepatology · doi:10.1002/hep.26081 · Cited by 282
Bertola, A., Park, O., & Gao, B. (2013) · Hepatology · doi:10.1002/hep.26419 · Cited by 282
Interleukin-1 participates in the progression from liver injury to fibrosis
Gieling, R. G., Wallace, K., & Han, Y.-P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90564.2008 · Cited by 281
Moschen, A. R., Molnar, C., Geiger, S., Graziadei, I., Ebenbichler, C. F., Weiss, H., Kaser, S., Kaser, A., & Tilg, H. (2010) · Gut · doi:10.1136/gut.2010.214577 · Cited by 267
Self-citationCaspase-1: is IL-1 just the tip of the ICEberg?
Denes, A., Lopez-Castejon, G., & Brough, D. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.86 · Cited by 265
Dominguez, M., Miquel, R., Colmenero, J., Moreno, M., García–Pagán, J., Bosch, J., Arroyo, V., Ginès, P., Caballería, J., & Bataller, R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.056 · Cited by 238
Al-Sadi, R., Ye, D., Said, H. M., & Ma, T. Y. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100371 · Cited by 217
Inflammation links excess fat to insulin resistance: the role of the interleukin‐1 family
Tack, C. J., Stienstra, R., Joosten, L. A. B., & Netea, M. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01145.x · Cited by 193
Nuclear Factor-Eythroid 2–Related Factor 2 Prevents Alcohol-Induced Fulminant Liver Injury
Lamlé, J., Marhenke, S., Borlak, J., von Wasielewski, R., Eriksson, C. J. P., Geffers, R., Manns, M. P., Yamamoto, M., & Vogel, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.011 · Cited by 193
Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
Dixon, L. J., Flask, C. A., Papouchado, B. G., Feldstein, A. E., & Nagy, L. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056100 · Cited by 188
Moschen, A. R., Molnar, C., Enrich, B., Geiger, S., Ebenbichler, C. F., & Tilg, H. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00108 · Cited by 184
Self-citationSEKIYAMA, K. D., YOSHIBA, M., & THOMSON, A. W. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06609.x · Cited by 181
IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
Negrin, K. A., Roth Flach, R. J., DiStefano, M. T., Matevossian, A., Friedline, R. H., Jung, D., Kim, J. K., & Czech, M. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107265 · Cited by 168
Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
Liu, S., Hatano, B., Zhao, M., Yen, C.-C., Kang, K., Reilly, S. M., Gangl, M. R., Görgün, C. Z., Balschi, J. A., Ntambi, J. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138115 · Cited by 163
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
Dixon, L. J., Berk, M., Thapaliya, S., Papouchado, B. G., & Feldstein, A. E. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.45 · Cited by 158
Petrášek, J., Iracheta‐Vellve, A., Saha, B., Satishchandran, A., Kodys, K., Fitzgerald, K. A., Kurt‐Jones, E. A., & Szabó, G. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab1214-590r · Cited by 158
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
Iwaisako, K., Haimerl, M., Paik, Y.-H., Taura, K., Kodama, Y., Sirlin, C., Yu, E., Yu, R. T., Downes, M., Evans, R. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202464109 · Cited by 157
Han, Y., Zhou, L., Wang, J., Xiong, S., Garner, W. L., French, S. W., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310999200 · Cited by 155
Ganz, M., Bukong, T. N., Csák, T., Saha, B., Park, J., Ambade, A., Kodys, K., & Szabó, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0552-7 · Cited by 149
Nov, O., Shapiro, H., Ovadia, H., Tarnovscki, T., Dvir, I., Shemesh, E., Kovsan, J., Shelef, I., Carmi, Y., Voronov, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053626 · Cited by 147
Qin, X., Xie, X., Fan, Y., Tian, J., Guan, Y., Wang, X., Zhu, Y., & Wang, N. (2008) · Hepatology · doi:10.1002/hep.22334 · Cited by 147
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice
Cui, K., Yan, G., Xu, C., Chen, Y., Wang, J., Zhou, R., Bai, L., Lian, Z., Wei, H., Sun, R., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.027 · Cited by 144
Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
Yang, S. J., & Lim, Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.003 · Cited by 142
Iracheta‐Vellve, A., Petrášek, J., Satishchandran, A., Gyöngyösi, B., Saha, B., Kodys, K., Fitzgerald, K. A., Kurt‐Jones, E. A., & Szabó, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.013 · Cited by 141
Dinarello, C. A., Rosenwasser, L. J., & Wolff, S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2517 · Cited by 132
Management of alcoholic hepatitis
Mathurin, P., & Lucey, M. R. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60005-1 · Cited by 126
Serum interleukin-1 (IL-1) activity in alcoholic hepatitis
McClain, C. J., Cohen, D. A., Dinarello, C. A., Cannon, J. G., Shedlofsky, S. I., & Kaplan, A. M. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90554-0 · Cited by 121
Somm, E., Cettour-Rose, P., Asensio, C., Charollais, A., Klein, M., Theander-Carrillo, C., Juge-Aubry, C. E., Dayer, J. M., Nicklin, M. J. H., Meda, P., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0046-x · Cited by 111
Mechanism of Interleukin-1β Induced-Increase in Mouse Intestinal Permeability In Vivo
Al–Sadi, R., Guo, S., Dokładny, K., Smith, M. A., Ye, D., Kaza, A., Watterson, D. M., & Ma, T. Y. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0031 · Cited by 111
Csák, T., Pillai, A., Ganz, M., Lippai, D., Petrasek, J., Park, J., Kodys, K., Dolganiuc, A., Kurt‐Jones, E. A., & Szabó, G. (2014) · Liver International · doi:10.1111/liv.12537 · Cited by 97
Circulating Levels of Interleukin-1 Family Cytokines in Overweight Adolescents
Jung, C., Gerdes, N., Fritzenwanger, M., & Figulla, H. R. (2010) · Mediators of Inflammation · doi:10.1155/2010/958403 · Cited by 64
Vallés, S. L., Blanco, A. M. A., Azorı́n, I., Guasch, R. M., Pascual, M., Gómez-Lechón, M. J., Renau‐Piqueras, J., & Guerri, C. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000099261.87880.21 · Cited by 64
The role of apolipoprotein A5 in non-alcoholic fatty liver disease
Ress, C., Moschen, A. R., Sausgruber, N., Tschoner, A., Graziadei, I., Weiss, H., Schgoer, W., Ebenbichler, C. F., Konrad, R. J., Patsch, J. R., et al. (2011) · Gut · doi:10.1136/gut.2010.222224 · Cited by 49
Self-citationOlteanu, S., Kandel-Kfir, M., Shaish, A., Almog, T., Shemesh, S. S., Barshack, I., Apte, R. N., Harats, D., & Kamari, Y. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.01.156 · Cited by 48
de Roos, B., Rungapamestry, V., Ross, K., Rucklidge, G. J., Reid, M., Duncan, G., Horgan, G. W., Toomey, S., Browne, J. A., Loscher, C. E., et al. (2009) · PROTEOMICS · doi:10.1002/pmic.200800761 · Cited by 47
IL-1 cytokine family members and NAFLD: Neglected in metabolic liver inflammation
Tilg, H., & Moschen, A. R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.007 · Cited by 44
Self-citationMadsen, E. L., Bruun, J. M., Skogstrand, K., Hougaard, D. M., Christiansen, T., & Richelsen, B. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.031 · Cited by 43
Hanck, C., Manigold, T., Böcker, U., Kurimoto, M., Kölbel, C. B., Singer, M. V., & Rossol, S. (2001) · Gut · doi:10.1136/gut.49.1.106 · Cited by 29
Interleukin‐18 Protein Level Is Upregulated in Adipose Tissue of Obese Mice
Membrez, M., Ammon‐Zufferey, C., Philippe, D., Aprikian, O., Monnard, I., Macé, K., & Darimont, C. (2008) · Obesity · doi:10.1038/oby.2008.535 · Cited by 27
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Sanyal, A. J., Gao, B., & Szabó, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.015 · Cited by 22
Spahr, L., Garcia, I., Bresson‐Hadni, S., Rubbia‐Brandt, L., Guler, R., Olleros, M. L., Chvatchko, Y., & Hadengue, A. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0967.x · Cited by 21
Ludwiczek, O., Vannier, E. G., Moschen, A. R., Salazar-Montes, A. M., Borggraefe, I., Gabay, C., Enrich, B., Kaser, A., Siegmund, B., Dinarello, C. A., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802179925 · Cited by 20
Self-citation
Cited by
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Immunotherapies for hepatocellular carcinoma
Llovet, J. M., Castet, F., Heikenwalder, M., Maini, M. K., Mazzaferro, V., Pinato, D. J., Pikarsky, E., Zhu, A. X., & Finn, R. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00573-2 · Cited by 1,843
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Self-citation
Metadata
- Authors
- Tilg, H., Moschen, A. R., & Szabo, G.
- Venue
- Hepatology
- Published
- 2016-03-09
- Volume
- 64
- Issue
- 3
- Pages
- 955-965
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2514873437
- Cited by
- 319
- References
- 94
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.